«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

Similar documents
Low Gradient Severe? AS

Aortic Valve Replacement Improves Outcome in Patients with Preserved Ejection Fraction: PRO!

Low Gradient AS: Multi-Imaging Modalities

Sténose aortique à Bas Débit et Bas Gradient

Indicator Mild Moderate Severe

Aortic Valvular Stenosis

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Managing the Low Output Low Gradient Aortic Stenosis Patient

Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor

The best in heart valve disease Aortic valve stenosis

Aortic Valve Stenosis: Flow and Gradient stratification and association with TAVR outcomes

Paradoxical low flow-low gradient severe aortic stenosis: where are we?

MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS

Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis?

Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan

Aortic stenosis aetiology: morphology of calcific AS,

How to Avoid Prosthesis-Patient Mismatch

Outcome of Patients With Aortic Stenosis, Small Valve Area, and Low-Flow, Low-Gradient Despite Preserved Left Ventricular Ejection Fraction

Stage of Valvular AS. Outline 10/14/16. Low-flow and Other Challenges to the Assessment of Aortic Stenosis. Severe AS

Low gradient severe aortic stenosis with preserved left ventricular ejection fraction

Spotlight on Valvular Heart Disease Guidelines

Natural History and Echo Evaluation of Aortic Stenosis

Low Gradient AS Normal LVEF

Valvular Guidelines: The Past, the Present, the Future

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Clinical Outcome in Patients with Aortic Stenosis

Aortic Valve Stenosis: When stress TTE and/or TEE is required to make the diagnosis and guide treatment

Comprehensive Echo Assessment of Aortic Stenosis

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

AS with reduced LV ejection fraction: Contractile reserve should be systematically assessed: PRO

Aortic valve Stenosis: Insights in the evaluation of LV function. Erwan DONAL Cardiologie CHU Rennes


Workshop Facing the challenge of TAVI 2016

Mixed aortic valve disease

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic

Stress Testing in Valvular Disease

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

Nothing to Disclose. Questions. Disclosure Asymptomatic Severe Aortic Stenosis: (When) Should One Intervene? Paul Wood at the Nathanson Lecture, 1958

Paravalvular Regurgitation is a Risk Factor Following TAVI

Five-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe Aortic Stenosis: The PARTNER Trial

A patient with aortic stenosis and LV dysfunction EuroECHO & Other Imaging Modalities 2012 Athens, Greece

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

Mild paravalvular regurgitation is not an independent predictor of mortality following TAVI

Vinod H. Thourani, MD

Aortic Valve Stenosis: Medical Treatment, Still in the Pipeline?

New imaging modalities for assessment of TAVI procedure and results. R Dulgheru, MD Heart Valve Clinic CHU, Liege

TAVR: Echo Measurements Pre, Post And Intra Procedure

ESC / EACTS new valvular guidelines- Update

Michigan Society of Echocardiography 30 th Year Jubilee

Relevant Financial Relationship(s) Off Label Usage. None. None

Primary Mitral Regurgitation

Management of significant asymptomatic aortic stenosis. Alec Vahanian Bichat Hospital University Paris VII Paris, France

Prosthetic valve dysfunction: stenosis or regurgitation

Usually we DON T need to go beyond the gradient

Low-Flow, Low-Gradient Aortic Stenosis With Normal and Depressed Left Ventricular Ejection Fraction

Aortic Stenosis Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan

Severe Aortic Stenosis with Low Gradient and Preserved Ejection Fraction

Valve Replacement for Severe Aortic Stenosis With Low Transvalvular Gradient and Left Ventricular Ejection Fraction Exceeding 0.50

2/15/2018 DISCLOSURES OBJECTIVES. Consultant for BioSense Webster, a J&J Co. Aortic stenosis background. Short history of TAVR

Exercise Testing/Echocardiography in Asymptomatic AS

Patient/prosthesis mismatch: how to evaluate and when to act?

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology

Assessing Function by Echocardiography in VHD Asymptomatic Severe Organic MR. Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM

Management of Difficult Aortic Root, Old and New solutions

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid

Echo evaluation for TAVR. From the General Cardiologist to the Interventional Echocardiologist

Chronic Primary Mitral Regurgitation

Low-flow, low-gradient (LG) severe aortic stenosis (AS)

Prof. JL Zamorano Hospital Universitario Ramón y Cajal

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Valvular Intervention

Η ηχωκαρδιολογία στην διάγνωση κα πρόγνωση της καρδιακής ανεπάρκειας µε µειωµένο και φυσιολογικό κλάσµα εξώθησης

The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation

Independent Effect of Low Flow on Outcomes in Patients Undergoing Aortic Valve Replacement for Severe Aortic Stenosis

TAVR IN INTERMEDIATE-RISK PATIENTS

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France

MITRAL STENOSIS: MANY FLAVORS Rheumatic and Calcification. Rheumatic Mitral Stenosis 76yo male

2017 ESC/EACTS Guidelines for the management of valvular heart disease

A new way to look at the aortic valve

B-type Natriuretic Peptide in VHD: a Non-imaging Helper for the Cardiologist. Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE

Culprit vs Multivalve Transcatheter Intervention

A Health Care Professional s Guide Aortic Stenosis in Seniors

Potential conflicts of interest

Early Surgery in Asymptomatic Severe Aortic Stenosis Pros and Cons

Affecting the elderly Requiring new approaches. Echocardiographic Evaluation of Hemodynamic Severity. Increasing prevalence Mostly degenerative

Echocardiographic evaluation of mitral stenosis

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

STRUCTURAL. aortic stenosis, transcatheter aortic valve replacement

PARAVALVULAR LEAK POST TAVR. Elements of Follow-up Post TAVR

Constriction vs Restriction Case-based Discussion

New Imaging for Aortic Valve Disease. Anthony DeMaria Judy and Jack White Chair Director, Sulpizio CV Center University of California, San Diego

Worldwide rheumatic fever is the most common cause of valve disease. In industrialized areas, valvular disease of old age predominates

Diastolic Function Assessment New Guideline Update Practical Approach

Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis

Choose the grading of diastolic function in 82 yo woman

Transcription:

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer Philippe Pibarot, DVM, PhD, FACC, FAHA, FESC, FASE Canada Research Chair in Valvular Heart Diseases Université LAVAL

Disclosure: None except that Gilbert Habib is a very good friend!

Disclosure: None except that Gilbert Habib is a very good friend! This is a very hot topic!

There s No Smoke without Fire

Burning Questions about Paradoxical Low-Flow, Low-Gradient AS: Does it exist? Does it have impact on survival? Does AVR help?

Paradoxical Low-Flow, Low-Gradient AS: Does it exist?

NORMAL-LVEF NORMAL-FLOW HIGH-GRADIENT Two Different Patterns of Low-Flow, Low-Gradient AS 50-70% NORMAL-LVEF «PARADOXICAL» LOW-FLOW LOW-GRADIENT 10-15% LOW-LVEF «CLASSICAL» LOW-FLOW LOW-GRADIENT 5-10% Pibarot & Dumesnil JACC, 2012

Case Study 78 y.o. female with history of calcific AS NYHA class III Mild hypertension No evidence of obstructive CAD LVEF: 60% AS severity on echo: AVA: 0.7 cm 2 BSA: 1.7 m 2, indexed AVA: 0.4 cm 2 /m 2 Peak/mean gradient: 51/29 mmhg

Case Study: Discrepancy between AVA and Gradient LVEF: 60% Small LV cavity: LVEDD: 39 mm LVEDV: 79 ml

LVOT-D: 2.0 cm LVOT-A: 3.1 cm 2 LVOT-VTI: 15 cm Peak ΔP: 51 mmhg Mean ΔP: 29 mmhg Ao-VTI: 65 cm LVOT- SV: 46 ml (SVi=27 ml/m 2 ) 2D Volumetric method to corroborate SV measure: LVEDV (79 ml) LVEF (60%) = 48 ml / AVA: 0.7 cm 2

Dobutamine Stress Echocardiography Multislice CT 15 µg/kg/min Peak ΔP: 94 mmhg Mean ΔP: 57 mmhg AVA: 0.77 cm 2 Valve Calcium score: 1900 AU

Age Women Hypertension MetS - Diabetes Hachicha Z et al., Circulation, 2007 Dumesnil et al. Eur Heart J, 2009 Pibarot & Dumesnil JACC, in press, 2012

Patients with paradoxical low-flow AS have abnormal myocardial systolic function Adda et al. Circulation CV Imaging, 2012 Normal -Flow High Gradient Low-Flow Low-Gradient Lancellotti et al. Eur J Echo 2010 Lee et al. J Am Soc Echocardiogr, 2011

Pronounced Concentric Remodeling High Arterial Load Impaired Diastolic Filling Impaired Longitudinal systolic function Atrial Fibrillation Mitral Stenosis Mitral Regurgitation Tricuspid Regurgitation Ejection time Reduced Forward Stroke Volume Reduced Transvalvular flow rate Low-Flow AS Despite Preserved LVEF Pibarot & Dumesnil, Circulation 2013

Normal Flow AS Paradoxical Low-Flow AS LVEDV: 115 ml LVEF: 60% SV: 70 ml AVA: 0.7 cm 2 P: 45 mmhg LVEDV: 85 ml LVEF: 60% SV: 50 ml AVA: 0.7 cm 2 P: 25 mmhg

Prevalence of Paradoxical Low-Flow, Prevalence (%) 30 Low-Gradient AS 25 20 15 10 Colonne2 5 0 Hachicha 2006 Echo (512 pts) Barasch 2006 Echo (215 pts) Cramariuc 2009 Echo (1591 pts) Minners 2010 Echo (333 pts) Minners 2010 Cath (333 pts) Hermann 2011 Echo & Cath (86 pts) Adda 2011 Echo (150 pts) Lancellotti 2012 Echo (150 pts) Paradoxical Low-Flow, Low-Gradient AVA<1.0 cm 2; MG<40 mmhg LVEF>50%; SVi<35 ml/m 2 Mohty 2013 Cath (768 pts)

Lauten et al. JACC 2013 Invasive Hemodynamic Characteristics of Low-Flow, Low-Gradient Severe AS Despite Preserved LVEF Occurrence of paradoxical low-flow, low-gradient AS was confirmed by invasive hemodynamics and was not the result of a systematic bias in the echo calculation of AVA

Paradoxical Low-Flow, Low-Gradient AS: Does it have impact on survival?

Hachicha Z et al., Circulation. 115:2856-2864, 2007

Outcome of Patients with Paradoxical Low-Flow, Low-Gradient AS 150 Pts with asymptomatic severe (AVA<1.0 cm 2 ) AS LVEF>50% Lancellotti P, Magne J et al. J Am Coll Cardiol. 59:235 43, 2012

Outcome of Patients with Paradoxical Low-Flow, Low-Gradient AS Eleid et al. Circulation 2013 Ozkan Circulation 2013

Mohty et al. Circulation 2013 Outcome in Paradoxical Low-Flow, Low-Gradient Severe Aortic Stenosis and Preserved LVEF A Cardiac Catheterization Study

Outcome of Patients with Paradoxical Low-Flow, Low-Gradient AS Case Match Study: 3 187 patients Clavel et al. JACC 2012

Outcome of Patients with Paradoxical Low-Flow, Low-Gradient AS Conclusions: Patients with paradoxical LFLG AS exhibit marked concentric remodelling, impaired LV longitudinal function and worse prognosis Normal-flow, low-gradient AS patients have outcomes similar to moderate AS Mehrota et al. Eur Heart J 2013

Outcome of Patients With Low-Gradient "Severe" Aortic Stenosis and Preserved LVEF A Substudy of the SEAS trial AVA<1.0 ΔP<40 AVA: 1.0-1.5 ΔP<40 AVA<1.0 ΔP>40 Jander et al. Circulation. 2011;123:887-895.

Potential Causes of Discordance between AVA (e.g. 0.8) and gradient (e.g. 30) in Pts. With Preserved LVEF Measurement errors Small body size Inconsistency in guidelines criteria Paradoxical low-flow, low-gradient severe AS Minners et al. Eur Heart J, 2008

Paradoxical low flow severe AS Measurement error Small body size Inconsistency in guidelines criteria Jander et al. Circulation. 2011;123:887-895.

1.0 1.0 77 83

Criteria for Paradoxical low-flow AS EDD<47 mm EDV< 55 ml/m 2 RWT ratio > 0.50

N=69 N=28 Barone-Rochette, Circ CV Imaging 2013 N=17 N=14

Conclusion: Paradoxical low-flow, low-gradient AS is a associated with severe prognosis

Conclusion: Paradoxical low-flow, low-gradient AS is associated with severe prognosis. Its prognosis does not seem to be improved by surgery.

Paradoxical Low-Flow, Low-Gradient AS: Does AVR help?

Outcome of Patients with Paradoxical Low-Flow AS 70 60 50 40 30 20 512 Patients with indexed AVA<0.6 cm 2, LVEF 50% Percentage of Patients Treated Surgically NF 65 % 47 % PLF ΔP: 40±15 32±17 Hachicha Z et al., Circulation. 115:2856-2864, 2007 100 80 60 40 20 0 P < 0.001 Overall Survival (%) Surgical Surgical Medical Medical 0 1 2 3 4 5 Follow-up (years) NF: Normal Flow: SVI>35 (65%) PLF: Paradoxical Low Flow: SVI 35 (35%)

Impact of AVR on Survival in Patients with Paradoxical Low-Flow, Low-Gradient AS Clavel MA JACC in press Clavel et al. JACC 2012 Tarantini et al. Ann Thorac Surg, 91:1808 15, 2011

Impact of AVR on Survival According to LVEF in Patients with Low Gradient LVEF< 35% 168 patients AVA 0.8 cm 2 ΔP 30 mmhg LVEF < 35-54% LVEF 55% Pai et al., Ann Thorac Surg 86:1781 90, 2008

Impact of AVR on Survival in Patients with Low-Gradient Severe AS and Preserved LVEF 102 patients, AVA<1.0 cm 2 ΔP Mean < 40 mmhg LVEF 50% Whole Cohorts Propensity Score-Matched Cohorts Tarantini et al. Ann Thorac Surg, 91:1808 15, 2011

Impact of AVR on Outcome of Symptomatic Patients with Severe Stenosis, Low Gradient, and Preserved LVEF 260 symptomatic Pts Severe AS (AVAi<0.6 cm 2 /m 2 ) Low gradient (<40 mmhg) Preserved LVEF (>50%) Ozkan et al. Circulation 2013

Impact of AVR on Outcome of Symptomatic Patients with Severe Stenosis, Low Gradient, and Preserved LVEF 1704 Patients Eleid et al. Circulation 2013

2-Year Death (%) PARTNER-I (Cohorts A+B) Paradoxical LF, NEF, and LG (12% of cohort) 90% 80% 70% LF NEF LG A - TAVR LF NEF LG A - Surgery LF NEF LG B - TAVR LF NEF LG B - Std Rx log rank p= 0.003 76.9% 60% 50% 40% 30% 20% 56.5% 41.1% 39.7% 10% 0% 0 60 120 180 240 300 360 420 480 540 600 660 720 Days Numbers at Risk A TAVR 43 39 38 34 34 33 29 26 22 A Surgery 44 33 30 30 28 27 27 26 23 B TAVR 23 21 19 17 15 13 11 10 10 B Std Rx 29 22 15 10 9 9 6 5 4 Herrmann et al. Circulation 2013

2012 ESC/EACTS Guidelines on Management of VHD: Indications for AVR in AS The newly recognized entity of paradoxical low-flow, lowgradient AS with normal EF requires special attention because of the limited amount of data on the natural history and outcome after surgery Vahanian et al. EHJ 2012

LVEF 50% SVi<35 ml/m 2 AVA 1.0 ΔP<40 Symptomatic Exercise Stress Echo / Dobutamine Stress Echo MSCT AoV Ca Score ΔP 30-40 AVA<1.0-1.2 ΔP<30-40 AVA 1.0-1.2 <1200 <2000 >1200 >2000 True-Severe AS SAVR CABG TAVR PCI? BAV+TAVR? Pseudo-Severe AS HTN Therapy True-Severe AS SAVR CABG TAVR PCI? BAV+TAVR?

Answers to Burning Questions: Paradoxical low-flow, low-gradient AS Does it exist: YES! this a real entity that occurs in 10-15% of AS patients Does it have impact on survival: YES! Does AVR help: YES! AVR improves outcome in patients with true paradoxical low-flow, lowgradient severe AS TAVR may provide a valuable alternative to SAVR

Key Messages: Paradoxical Low-Flow AS When confronted to AVA-gradient discordance: 1- Rule out measurement errors 2- Rule out small body size 3- Document the presence of low-flow: SVi<35 ml/m 2 4- Identify typical echo features of paradoxical LFLG: Small LV with concentric remodeling, impaired filling, reduced longitudinal function 5- Identify other causes of low flow: AFib, MR, TR, MS, bradychardia 6- Rule out pseudo-severe AS: MSCT and stress echo